BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 30, 2019
View Archived Issues
Alpha-synuclein and autophagy
Read More
Hypothermia activates hypoxia protein, benefits metabolism
Read More
First green tea-triggered genetic control system reported
Read More
Positive clinical data presented for omburtamab
Read More
CLDN6 identified as a tumor-promoting gene in gastric cancer
Read More
Data presented for the oral, clinical stage, class I specific HDACi OKI-179
Read More
Kinesins are involved in the pathophysiology of genetically undiagnosed Rett syndrome
Read More
Adenoviral gene therapy rescues eukaryotic translation elongation factor 1 alpha 2 knockout in mice
Read More
New GABA-A receptor alpha 5 PAM with pro-cognitive, anxiolytic and antidepressant effects in mice
Read More
First patient dosed in phase I/II study of LNS-8801 in patients with advanced cancer
Read More
Themis Bioscience and CEPI initiate phase I study of Lassa fever vaccine candidate
Read More
FTO variant rs9939609 as a new genetic biomarker in Crohn's disease
Read More
FORMA Therapeutics discloses new histone deacetylase 8 inhibitors
Read More
Dihydroorotate dehydrogenase inhibitors discovered at Bayer
Read More
East China University of Science and Technology patents dihydroorotate dehydrogenase inhibitors
Read More
Dalian Institute of Chemical Physics CAS patents muscarinic M1/ M3 receptor antagonists
Read More
Proline derivatives identified at Qingdao Marine Biomedical Research Institute
Read More
Dosing begins in first-in-human study of UCARTCS1 for relapsed/refractory multiple myeloma
Read More
European Commission approves Dupixent for chronic rhinosinusitis with nasal polyposis
Read More
FDA places partial hold on AVXS-101 intrathecal clinical trials
Read More
CytomX initiates phase II study of CX-072 with ipilimumab in relapsed or refractory melanoma
Read More
miRagen Therapeutics reports on miR-29 programs
Read More